Pregnancy Point of Care Testing Market to Expand with Increasing Adoption of Rapid Diagnostic Testing and Point of Care Devices

It is anticipated that the global pregnancy point of care testing market would generate US$ 2.33 billion in sales, up from its current value of US$ 1.5 billion in 2023. Over the next 10 years, the demand for point-of-care pregnancy testing is expected to increase globally at a 4.5% CAGR. The Pregnancy Point of Care Testing (POCT) Market refers to the market for medical diagnostic tests that are performed at or near the point of care, typically at the bedside or in a physician's office, and used to confirm or rule out pregnancy.

This market is driven by the increasing demand for accurate and convenient diagnostic testing methods for pregnancy, as well as the rising awareness among women about the importance of prenatal care. The market includes various types of POCT devices, including urine-based tests, blood-based tests, and others. The global pregnancy POCT market is expected to experience significant growth over the next few years, driven by increasing demand for these tests in developing countries, rising awareness about the benefits of early pregnancy diagnosis, and advancements in technology.

𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗙𝗿𝗲𝗲 𝗦𝗮𝗺𝗽𝗹𝗲 𝗖𝗼𝗽𝘆 𝗼𝗳 𝘁𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁 -https://www.factmr.com/connectus/sample?flag=S&rep_id=3560

However, the market also faces some challenges, such as the high cost of these tests and the lack of skilled healthcare professionals to perform them in some regions. Additionally, the COVID-19 pandemic has also had a significant impact on the market, with disruptions in supply chains and changes in healthcare policies affecting demand for these tests.

𝗞𝗲𝘆 𝗧𝗮𝗸𝗲𝗮𝘄𝗮𝘆𝘀 𝗳𝗿𝗼𝗺 𝗣𝗿𝗲𝗴𝗻𝗮𝗻𝗰𝘆 𝗣𝗼𝗶𝗻𝘁 𝗼𝗳 𝗖𝗮𝗿𝗲 𝗧𝗲𝘀𝘁𝗶𝗻𝗴 𝗠𝗮𝗿𝗸𝗲𝘁 𝗦𝘂𝗿𝘃𝗲𝘆

Sales of strips/dipsticks and card-based pregnancy test kits are anticipated to remain high.
Urine-based pregnancy test kits are expected to emerge as the most preferred sample type.
Pharmacies and drugstores are projected to account for maximum sales of pregnancy point of care testing products, followed by online retail channels.
The U.S. is projected to dominate the North America market owing to the presence of key market players and high awareness regarding women's health and pregnancy.
South Asia will emerge as a lucrative pocket over the forecast period due to increasing preference for home monitoring devices in South Asia counties.
Reginal Analysi

North America: The North American market is expected to dominate the global Pregnancy POCT market owing to the high adoption rate of these tests, favorable reimbursement policies, and the presence of major market players in the region.
Europe: The European market is also expected to show significant growth due to increasing awareness and adoption of pregnancy POCT tests, rising disposable income, and supportive healthcare policies.
Asia-Pacific: The Asia-Pacific region is expected to be the fastest-growing market due to increasing government initiatives for improving healthcare infrastructure and rising awareness of prenatal care. Additionally, increasing demand for rapid and accurate diagnosis in the region is expected to boost market growth.
Latin America: The Latin American market is also expected to show significant growth due to rising healthcare expenditure and government initiatives to improve healthcare infrastructure.
Middle East & Africa: The Middle East and African market is expected to grow at a moderate pace due to increasing government initiatives to improve healthcare infrastructure and rising awareness about prenatal care.

𝗚𝗲𝘁 𝗖𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗼𝗻 𝘁𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁 𝗳𝗼𝗿 𝗦𝗽𝗲𝗰𝗶𝗳𝗶𝗰 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀 - https://www.factmr.com/connectus/sample?flag=RC&rep_id=3560

𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗟𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲

Leading players operating in the global pregnancy point of care testing market are improving their product portfolio by investing in strategic collaborations, mergers, and acquisitions. Besides this, collaborations with regional healthcare authorities and non-governmental welfare organizations are anticipated to assist manufacturers in establishing a firm foothold in the market.

For instance:

In July 2018, a U.S. based company active in point of care testing market, NOW Diagnostics Inc. announced the acquisition of Cellmic LLC, a manufacturer of mobile phone-based holographic imaging and diagnostics in the U.S. Through this acquisition, the company aimed at positioning itself as a key player in the diagnostic and mobile space.

𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗣𝗿𝗲𝗴𝗻𝗮𝗻𝗰𝘆 𝗣𝗼𝗶𝗻𝘁 𝗼𝗳 𝗖𝗮𝗿𝗲 𝗧𝗲𝘀𝘁𝗶𝗻𝗴 𝗠𝗮𝗿𝗸𝗲𝘁 𝗜𝗻𝗰𝗹𝘂𝗱𝗲:

Abbott Laboratories
Quidel Corporation
Prestige Brands Holdings
Swiss Precision Diagnostics (SPD) GmbH
BIOSYNEX SA
EKF Diagnostics Holdings plc
NOW Diagnostics Inc
NG BIOTECH SAS
ulti med Products (Deutschland) GmbH
Procter & Gamble Co.
Piramal Enterprises
bioMérieux SA
Atlas Medical UK
Home Health (UK) Ltd

𝗙𝗼𝗿 𝗶𝗻-𝗱𝗲𝗽𝘁𝗵 𝗰𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗮𝗻𝗮𝗹𝘆𝘀𝗶𝘀, 𝗕𝘂𝘆 𝗡𝗼𝘄 -https://www.factmr.com/checkout/3560

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email : sales@factmr.com
Website : https://www.factmr.com

Market research and consulting agency with a difference! That's why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range - from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we'll be an able research partner.

This release was published on openPR.